These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 29153267)

  • 1. How to eliminate HCV in people who inject drugs in the USA.
    Dahari H; Boodram B
    Lancet Infect Dis; 2018 Feb; 18(2):134-135. PubMed ID: 29153267
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study.
    Zelenev A; Li J; Mazhnaya A; Basu S; Altice FL
    Lancet Infect Dis; 2018 Feb; 18(2):215-224. PubMed ID: 29153265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prioritising treatment among people who inject drugs in order to eliminate hepatitis C: addressing reluctance with sound economic analyses.
    Hutin YJ; Wiktor SZ
    Gut; 2017 Dec; 66(12):2052-2053. PubMed ID: 27566128
    [No Abstract]   [Full Text] [Related]  

  • 4. Review article: treatment as prevention - targeting people who inject drugs as a pathway towards hepatitis C eradication.
    Leask JD; Dillon JF
    Aliment Pharmacol Ther; 2016 Jul; 44(2):145-56. PubMed ID: 27199103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic hepatitis C testing of people in treatment for substance use disorders in Belgium between 2011 and 2014 : a cross-sectional study.
    Van Baelen L; Antoine J; De Ridder K; Muyldermans G; Gremeaux L
    Acta Gastroenterol Belg; 2019; 82(1):35-42. PubMed ID: 30888752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary on Mahmud et al. (2020): Hepatitis C elimination efforts need to include people who inject drugs in the Middle East and North Africa.
    Walsh N
    Addiction; 2020 Jul; 115(7):1263-1264. PubMed ID: 32293761
    [No Abstract]   [Full Text] [Related]  

  • 7. Short and sporadic injecting cessation episodes as predictors of incident hepatitis C virus infection: findings from a cohort study of people who inject drugs in Montréal, Canada.
    Fortier E; Artenie AA; Zang G; Jutras-Aswad D; Roy É; Grebely J; Bruneau J
    Addiction; 2019 Aug; 114(8):1495-1503. PubMed ID: 30957310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus treatment as prevention in people who inject drugs.
    White PJ; Abubakar I
    Lancet Infect Dis; 2018 Apr; 18(4):379. PubMed ID: 29582763
    [No Abstract]   [Full Text] [Related]  

  • 9. Age-Related Differences in Past or Present Hepatitis C Virus Infection Among People Who Inject Drugs: National Human Immunodeficiency Virus Behavioral Surveillance, 8 US Cities, 2015.
    Abara WE; Trujillo L; Broz D; Finlayson T; Teshale E; Paz-Bailey G; Glick S; Al-Tayyib AA; Robinson WT; Masiello-Schuette S; Sey EK; Anderson BJ; Poe J; Braunstein S
    J Infect Dis; 2019 Jul; 220(3):377-385. PubMed ID: 30915477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to end treatment restrictions for people with hepatitis C who inject drugs.
    Rosenthal ES; Kattakuzhy S; Kottilil S
    Lancet Gastroenterol Hepatol; 2018 Mar; 3(3):142-143. PubMed ID: 29310927
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.
    Semá Baltazar C; Boothe M; Kellogg T; Ricardo P; Sathane I; Fazito E; Raymond HF; Temmerman M; Luchters S
    BMC Public Health; 2020 Jun; 20(1):851. PubMed ID: 32493347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contradictory advice for people who inject drugs in the 2016 EASL Recommendations on Treatment of Hepatitis C.
    Grebely J; Swan T; Hickman M; Bruneau J; Bruggmann P; Dalgard O; Litwin A; Backmund M; Dore GJ;
    J Hepatol; 2017 May; 66(5):1101-1103. PubMed ID: 28167323
    [No Abstract]   [Full Text] [Related]  

  • 13. Integrating hepatitis C and addiction care for people who inject drugs in the era of direct-acting antiviral therapy.
    Bird K; Socías ME; Ti L
    Int J Drug Policy; 2018 Sep; 59():1-2. PubMed ID: 29960218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reply to: "Contradictory advice for people who inject drugs in the 2016 EASL Recommendations on Treatment of Hepatitis C".
    EASL Recommendations for Treatment of Hepatitis C 2016 Panel. Electronic address: easloffice@easloffice.eu
    J Hepatol; 2017 May; 66(5):1103. PubMed ID: 28167321
    [No Abstract]   [Full Text] [Related]  

  • 15. Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia.
    Bajis S; Maher L; Treloar C; Hajarizadeh B; Lamoury FMJ; Mowat Y; Schulz M; Marshall AD; Cunningham EB; Cock V; Ezard N; Gorton C; Hayllar J; Smith J; Whelan M; Martinello M; Applegate TL; Dore GJ; Grebely J;
    Int J Drug Policy; 2018 Nov; 61():23-30. PubMed ID: 30388566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014.
    Blackburn NA; Patel RC; Zibbell JE
    Public Health Rep; 2016; 131 Suppl 2(Suppl 2):91-7. PubMed ID: 27168667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus infection in people who inject drugs in Africa.
    Shah R; Boucheron P; Mandaliya K; Kattamaiyo A; Chevaliez S; Shimakawa Y; Songok E; Lemoine M
    Lancet Infect Dis; 2020 Mar; 20(3):282-283. PubMed ID: 32112757
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis C virus infection in people who inject drugs in Africa.
    Kim JU; Mohamed Z; Mbwambo J; Rwegasha J; Lemoine M
    Lancet Infect Dis; 2020 Mar; 20(3):283-284. PubMed ID: 32112758
    [No Abstract]   [Full Text] [Related]  

  • 19. Indications of immune protection from hepatitis C infection.
    Aitken CK; Bowden S; Hellard M; Crofts N
    J Urban Health; 2004 Mar; 81(1):58-60. PubMed ID: 15047784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engaging people who inject drugs in hepatitis C virus testing and prevention through community-based outreach, in Sydney, Australia.
    Coupland H; White B; Bates A; Park JN; Iversen J; Maher L
    Drug Alcohol Rev; 2019 Feb; 38(2):177-184. PubMed ID: 30652363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.